Wearable Device and Behavioral Support for Enhancing Arm Use After Stroke
Sensor Enhanced Activity Motivation After Stroke
1 other identifier
interventional
32
1 country
1
Brief Summary
The goal of this study is to determine the effectiveness of behavioral support and feedback from a wearable device that senses arm movement in improving upper extremity function in a pilot, randomized controlled trial with chronic stroke patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2025
CompletedFirst Posted
Study publicly available on registry
June 27, 2025
CompletedStudy Start
First participant enrolled
August 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 29, 2026
CompletedAugust 19, 2025
August 1, 2025
4 months
May 19, 2025
August 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Variability Measurement
The amount of variability for the impaired upper extremity will be quantified by the variety of movements performed.
From enrollment to the end of treatment and follow up measurement (9 weeks)
Secondary Outcomes (10)
Active Time
From enrollment to the end of treatment and follow up measurement (9 weeks)
Fugl-Meyer Arm Motor Assessment
Initial Visit, First follow up, Second follow up
Box and Blocks Test
Initial Visit, First follow up, second follow up
Nine Hole Peg Test
Initial Visit, First follow up, Second follow up
Motor Activity Log (MAL)
Initial Visit, First follow up, Second follow up
- +5 more secondary outcomes
Other Outcomes (6)
Geriatric Depression Scale
Initial Visit, First follow up, Second follow up
Intrinsic Motivation Inventory (IMI)
Initial Visit, First follow up, Second follow up
Modified Ashworth Spasticity Scale
Initial Visit, First follow up, Second follow up
- +3 more other outcomes
Study Arms (2)
Movement Variability
EXPERIMENTALThe movement variability group will have a smartwatch app that records movement variability. Their movement goal will be centered on increasing their total movement variability as measured by the watch.
Active Time (Control)
PLACEBO COMPARATORThis group will only receive active-time feedback (the number of minutes and hours moving the upper extremity). Their goal will focus on increasing their total movement time.
Interventions
This app measures movement variability in the upper extremity as described in our previous study (doi:10.3390/s24165266).
The other software we are using measures total active time of the upper extremity.
Motivational Interviewing is an established therapeutic technique designed to increase patient adherence to therapy by addressing ambivalence. The motivational Interviewing sessions will include a variety of techniques such as: Open ended questions, Active Listening, Affirmation, Summarization, Questions focused on change talk, and Providing Information.
Eligibility Criteria
You may qualify if:
- to 85 years of age
- Experienced a single or multiple, ischemic or hemorrhagic stroke, with unilateral weakness, over six months previously
- An ability to score at least 3 blocks on the Box and Block Test. BBT score of the affected arm is at least 5% worse than that present with the unaffected arm.
- Absence of major depression, as defined by DSM V criteria or a score on the Geriatric Depression Scale \< 10.
You may not qualify if:
- Any substantial decrease in alertness, language reception, or attention
- Single or multiple, ischemic or hemorrhagic stroke less than 6 months ago
- Severe muscle tone at the upper extremity (score ≥ 3 on the Modified Ashworth Spasticity scale)
- Pregnant or lactating
- Advanced liver, kidney, cardiac, or pulmonary disease
- Coexistent major neurological disease
- Coexistent major psychiatric disease
- Plans to alter any current participation in other rehabilitation therapy in the time period of the study
- A terminal medical diagnosis consistent with survival \< 1 year
- A history of significant alcohol or drug abuse in the prior 3 years
- Current enrollment in another study related to stroke or stroke recovery
- Any other medical contraindication to participation in the study, as evaluated by our team physician.
- Visual Analog of Pain Scale Score of 7 or greater
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California Irvine
Irvine, California, 92697, United States
Related Publications (1)
Schwerz de Lucena D, Rowe JB, Okita S, Chan V, Cramer SC, Reinkensmeyer DJ. Providing Real-Time Wearable Feedback to Increase Hand Use after Stroke: A Randomized, Controlled Trial. Sensors (Basel). 2022 Sep 14;22(18):6938. doi: 10.3390/s22186938.
PMID: 36146287BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Reinkensmeyer, PhD
University of California, Irvine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Single (Outcomes Assessor)
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 19, 2025
First Posted
June 27, 2025
Study Start
August 20, 2025
Primary Completion
December 31, 2025
Study Completion
January 29, 2026
Last Updated
August 19, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share
We do not plan to share Individual Participant Data (IPD) with external researchers to ensure compliance with UCI's data management requirements, maintain participant confidentiality, and restrict access to approved UCI researchers using only deidentified data within our institution